Qiagen Projects Q4, 2015 Shortfalls; Reports Acquisition of Mo Bio Labs | GenomeWeb

This article has been updated with comments from Wells Fargo and corrected to acurately reflect the expected Q4 and FY 2015 EPS figures.

NEW YORK (GenomeWeb) – Qiagen today reported preliminary earnings for the fourth quarter and fiscal year 2015 that fell short of management's outlook and analyst expectations. The firm also reported a previously undisclosed acquisition of sample prep firm Mo Bio Laboratories.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.